Barthalomew Sillah
Geschäftsführer bei Avesta76 Therapeutics, Inc.
Profil
Barthalomew Sillah is currently working as an Investment Advisor at Ben Franklin Technology Partners, as the Chief Operating Officer at Avesta76 Therapeutics, Inc., as a member of the Investment Committee at The Penn Medicine – Wharton Fund for Health, and as a Managing Partner at Kola Global.
Previously, he worked as a Consultant at Albert Einstein Healthcare Network in 2017, as R&D Operations and Strategy at Spirovant Sciences, Inc. from 2017 to 2019, and as a Strategy Consultant at African Union from 2019 to 2020.
Dr. Sillah received his undergraduate degree from Harvard University in 2012, his MBA from The Wharton School of the University of Pennsylvania in 2017, and his doctorate from the University of Pennsylvania Medical Center in 2017.
Aktive Positionen von Barthalomew Sillah
| Unternehmen | Position | Beginn |
|---|---|---|
Wharton Fund For Health
 Wharton Fund For Health Investment ManagersFinance The Penn Medicine – Wharton Fund for Health (Wharton Fund For Health) is a venture capital firm founded in 2011. The firm is headquartered in Philadelphia, Pennsylvania. | Private Equity Investor | - |
Avesta76 Therapeutics, Inc.
 Avesta76 Therapeutics, Inc. BiotechnologyHealth Technology Avesta76 Therapeutics, Inc. develops medicines for cancer. The private company is based in Pasadena, CA. | Geschäftsführer | 01.08.2020 |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Berater | 01.06.2017 |
Ehemalige bekannte Positionen von Barthalomew Sillah
| Unternehmen | Position | Ende |
|---|---|---|
| African Union | Berater | 30.06.2020 |
Spirovant Sciences, Inc.
 Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Spirovant Sciences, Inc. is a gene therapy company, which engages in the development of gene therapies for cystic fibrosis and other lung diseases. It offers AAV platform which consists of a highly optimized transgene payload, a novel AAV capsid, and an augmenter; and lentiviral platform, a pseudotyped with an envelope protein which has demonstrated capability to transduce human airway epithelia from apical surfaces. Its pipeline include SPIRO-2101, SPIRO-2102, and SPIRO 2110. The company was founded by Joan Lau and Eric Yuen and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 31.05.2019 |
Albert Einstein Healthcare Network
 Albert Einstein Healthcare Network Hospital/Nursing ManagementHealth Services Albert Einstein Healthcare Network operates general hospitals. Its Belmont Behavioral Health facilities provide treatment for bariatric surgery, cancer, heart and vascular, obstetrics and gynecology, organ transplantation and orthopedics. The company is headquartered in Philadelphia, PA. | Berater | 30.11.2017 |
Ausbildung von Barthalomew Sillah
| Harvard University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| University of Pennsylvania Medical Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Albert Einstein Healthcare Network
Albert Einstein Healthcare Network Hospital/Nursing ManagementHealth Services Albert Einstein Healthcare Network operates general hospitals. Its Belmont Behavioral Health facilities provide treatment for bariatric surgery, cancer, heart and vascular, obstetrics and gynecology, organ transplantation and orthopedics. The company is headquartered in Philadelphia, PA. | Health Services |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
| African Union | Government |
Spirovant Sciences, Inc.
Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Spirovant Sciences, Inc. is a gene therapy company, which engages in the development of gene therapies for cystic fibrosis and other lung diseases. It offers AAV platform which consists of a highly optimized transgene payload, a novel AAV capsid, and an augmenter; and lentiviral platform, a pseudotyped with an envelope protein which has demonstrated capability to transduce human airway epithelia from apical surfaces. Its pipeline include SPIRO-2101, SPIRO-2102, and SPIRO 2110. The company was founded by Joan Lau and Eric Yuen and is headquartered in Philadelphia, PA. | Health Technology |
Avesta76 Therapeutics, Inc.
Avesta76 Therapeutics, Inc. BiotechnologyHealth Technology Avesta76 Therapeutics, Inc. develops medicines for cancer. The private company is based in Pasadena, CA. | Health Technology |
Wharton Fund For Health
Wharton Fund For Health Investment ManagersFinance The Penn Medicine – Wharton Fund for Health (Wharton Fund For Health) is a venture capital firm founded in 2011. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |